col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


131 Results       Page 1

 [1] 
Elsevier: Biochemical and Biophysical Research Communications
  original article Date Title Authors   All Authors
1 [GO] 2023―May―18 Unwinding mechanism of SARS-CoV helicase (nsp13) in the presence of Ca2+, elucidated by biochemical and single-molecular studies Jeongmin Yu, Hyeryeon Im, Gwangrog Lee
2 [GO] 2023―May―02 SARS-CoV-2 Omicron subvariant spike N405 unlikely to rapidly deamidate Christopher A. Beaudoin, Emmanouela Petsolari, Samir W. Hamaia, Sharif Hala, Fadwa S. Alofi, Arun P. Pandurangan, et al. (+4)
3 [GO] 2023―Apr―18 Plasmacytoid dendritic cells stimulated with Lactococcus lactis strain Plasma produce soluble factors to suppress SARS-CoV-2 replication Hiroshi Ishii, Kenta Jounai, Ryohei Tsuji, Konomi Ohshio, Daiki Kaneda, Midori Okazaki, et al. (+3)
4 [GO] 2023―Apr―05 Mechanism of an RBM-targeted rabbit monoclonal antibody 9H1 neutralizing SARS-CoV-2 Xiaoyu Chu, Xinyu Ding, Yixuan Yang, Yuchi Lu, Tinghan Li, Yan Gao, et al. (+12)
5 [GO] 2023―Mar―23 Platelet αIIbβ3 integrin binds to SARS-CoV-2 spike protein of alpha strain but not wild type and omicron strains Koyu Ito, Kota Goto, Ryutaro Shirakawa, Hisanori Horiuchi, Kouetsu Ogasawara
6 [GO] 2023―Jan―19 Evaluation of a biotin-based surrogate virus neutralization test for detecting postvaccination antibodies against SARS-CoV-2 variants in sera Min-Ju Ahn, Jung-Ah Kang, Su Min Hong, Kyu-Sun Lee, Dong Ho Kim, Daesub Song, Dae Gwin Jeong
7 [GO] 2023―Jan―14 Ensitrelvir is effective against SARS-CoV-2 3CL protease mutants circulating globally Sho Kawashima, Yuki Matsui, Takumi Adachi, Yuji Morikawa, Kae Inoue, Shiori Takebayashi, et al. (+4)
8 [GO] 2022―Dec―05 Spike protein receptor-binding domains from SARS-CoV-2 variants of interest bind human ACE2 more tightly than the prototype spike protein Jermilia Charles, Nathan McCann, Victoria A. Ploplis, Francis J. Castellino
9 [GO] 2022―Sep―25 SARS-CoV-2-induced hypomethylation of the ferritin heavy chain (FTH1) gene underlies serum hyperferritinemia in severe COVID-19 patients Jibran Sualeh Muhammad, Gehad ElGhazali, Jasmin Shafarin, Mohammad G. Mohammad, Ameera Abu-Qiyas, Mawieh Hamad
10 [GO] 2022―Sep―07 Hotspot residues and resistance mutations in the nirmatrelvir-binding site of SARS-CoV-2 main protease: Design, identification, and correlation with globally circulating viral genomes Aditya K. Padhi, Timir Tripathi
11 [GO] 2022―Aug―14 Virtual screening and molecular dynamics simulation for identification of natural antiviral agents targeting SARS-CoV-2 NSP10 Huilin Zhao, Jin Liu, Lei He, Lichuan Zhang, Rilei Yu, Congmin Kang
12 [GO] 2022―Aug―04 SARS-CoV-2 spike S1 subunit protein-mediated increase of beta-secretase 1 (BACE1) impairs human brain vessel cells Ji-Young Choi, Jung Hyun Park, Chulman Jo, Kyung-Chang Kim, Young Ho Koh
13 [GO] 2022―Aug―02 ATP enhances the error-prone ribonucleotide incorporation by the SARS-CoV-2 RNA polymerase Yasin Pourfarjam, Zhijun Ma, In-Kwon Kim
14 [GO] 2022―Jul―08 Immunization with 674-685 fragment of SARS-Cov-2 spike protein induces neuroinflammation and impairs episodic memory of mice Olena Lykhmus, Olena Kalashnyk, Lyudmyla Koval, Olga Krynina, Serhiy Komisarenko, Maryna Skok
15 [GO] 2022―Jun―23 SARS-CoV-2 Spike mutations modify the interaction between virus Spike and human ACE2 receptors Pushpendra Mani Mishra, Farhan Anjum, Vladimir N. Uversky, Chayan Kanti Nandi
16 [GO] 2022―Jun―21 Diabetic Covid-19 severity: Impaired glucose tolerance and pathologic bone loss Jyotirmaya Behera, Jessica Ison, Michael J. Voor, Suresh C. Tyagi, Neetu Tyagi
17 [GO] 2022―May―25 Corrigendum to “Biochemical characterization of SARS-CoV-2 nucleocapsid protein” Weihong Zeng, Guangfeng Liu, Huan Ma, Dan Zhao, Yunru Yang, Muziying Liu, et al. (+10)
18 [GO] 2022―May―13 Anisodamine potently inhibits SARS-CoV-2 infection in vitro and targets its main protease Wei Wei, Ni Kong, Ming-Zhen Liu, Ting Han, Jun-Feng Xu, Chong Liu
19 [GO] 2022―May―02 A high-affinity aptamer with base-appended base-modified DNA bound to isolated authentic SARS-CoV-2 strains wild-type and B.1.617.2 (delta variant) Hirotaka Minagawa, Hirofumi Sawa, Tomoko Fujita, Shintaro Kato, Asumi Inaguma, Miwako Hirose, et al. (+7)
20 [GO] 2022―Apr―22 Crystal structure of SARS-CoV 3C-like protease with baicalein Jingwen Feng, Dongyang Li, Jin Zhang, Xiushan Yin, Jian Li
21 [GO] 2022―Apr―20 Highly polymerized proanthocyanidins (PAC) components from blueberry leaf and stem significantly inhibit SARS-CoV-2 infection via inhibition of ACE2 and viral 3CLpro enzymes Kazuhiro Sugamoto, Yuri L. Tanaka, Akatsuki Saito, Yoh Goto, Takayuki Nakayama, Tamaki Okabayashi, et al. (+2)
22 [GO] 2022―Mar―23 High-resolution melting analysis after nested PCR for the detection of SARS-CoV-2 spike protein G339D and D796Y variations Hiroshi Miyoshi, Ryu Ichinohe, Takuro Koshikawa
23 [GO] 2022―Mar―18 Structural insights revealed by crystal structure of B38-CAP, an isoenzyme of carboxypeptidase ACE2, the receptor of SARS-CoV-2 Peiyuan Liu, Yanfeng Zhang, Zibin Li, Jianwen Huang, Tao Wang, Cheng Chen
24 [GO] 2022―Mar―16 Evidence for investigating GSK-3 inhibitors as potential therapeutics for severe COVID-19 Davoud Ghazanfari, Maria Cecilia Courreges, Lydia Belinski, Stephen C. Bergmeier, Kelly D. McCall, Douglas J. Goetz
25 [GO] 2022―Mar―14 Harnessing coronavirus spike proteins' binding affinity to ACE2 receptor through A novel Baculovirus surface display system Lin Wang, Lixia Zhao, Yu Li, Peixiang Ma, Roger D. Kornberg, Yan Nie
26 [GO] 2022―Mar―10 Discovery of 4′-O-methylscutellarein as a potent SARS-CoV-2 main protease inhibitor Qianqian Wu, Shiqiang Yan, Yujie Wang, Maotian Li, Yibei Xiao, Yingxia Li
27 [GO] 2022―Feb―23 The stalk domain of SARS-CoV-2 NSP13 is essential for its helicase activity Kun Yue, Bin Yao, Yingchao Shi, Yang Yang, Zhaohui Qian, Yali Ci, Lei Shi
28 [GO] 2022―Jan―29 The function of SARS-CoV-2 spike protein is impaired by disulfide-bond disruption with mutation at cysteine-488 and by thiol-reactive N-acetyl-cysteine and glutathione Mana Murae, Yoshimi Shimizu, Yuichiro Yamamoto, Asuka Kobayashi, Masumi Houri, Tetsuya Inoue, et al. (+13)
29 [GO] 2022―Jan―15 How tetraspanin-mediated cell entry of SARS-CoV-2 can dysregulate the shedding of the ACE2 receptor by ADAM17 Eamonn F. Healy
30 [GO] 2021―Dec―30 Merbromin is a mixed-type inhibitor of 3-chyomotrypsin like protease of SARS-CoV-2 Junjie Chen, Yaya Zhang, Dequan Zeng, Bingchang Zhang, Xiaohong Ye, Zhiping Zeng, et al. (+3)
31 [GO] 2021―Dec―24 Mutations on RBD of SARS-CoV-2 Omicron variant result in stronger binding to human ACE2 receptor Cecylia S. Lupala, Yongjin Ye, Hong Chen, Xiao-Dong Su, Haiguang Liu
32 [GO] 2021―Nov―22 Emerging mutation patterns in SARS-CoV-2 variants David A. Ostrov, Glenn W. Knox
33 [GO] 2021―Nov―20 NSP9 of SARS-CoV-2 attenuates nuclear transport by hampering nucleoporin 62 dynamics and functions in host cells Kei Makiyama, Masaharu Hazawa, Akiko Kobayashi, Keesiang Lim, Dominic Chih-Cheng Voon, Richard Wong
34 [GO] 2021―Oct―21 Linking COVID-19 and Parkinson's disease: Targeting the role of Vitamin-D Tapan Behl, Sachin Kumar, Aayush Sehgal, Sukhbir Singh, Neelam Sharma, Sridevi Chirgurupati, et al. (+4)
35 [GO] 2021―Sep―23 SARS-CoV-2 spike protein receptor-binding domain N-glycans facilitate viral internalization in respiratory epithelial cells Luping Zheng, Yingxin Ma, Minghai Chen, Guoqiang Wu, Chuang Yan, Xian-En Zhang
36 [GO] 2021―Sep―15 SARS-CoV-2 triggers DNA damage response in Vero E6 cells Joshua Victor, Jamie Deutsch, Annalis Whitaker, Erica N. Lamkin, Anthony March, Pei Zhou, et al. (+2)
37 [GO] 2021―Sep―13 The in vitro and in vivo efficacy of CT-P59 against Gamma, Delta and its associated variants of SARS-CoV-2 Dong-Kyun Ryu, Bobin Kang, Hanmi Noh, Sun-Je Woo, Min-Ho Lee, Patricia M. Nuijten, et al. (+16)
38 [GO] 2021―Sep―08 Air-liquid interphase culture confers SARS-CoV-2 susceptibility to A549 alveolar epithelial cells Michihito Sasaki, Mai Kishimoto, Yukari Itakura, Koshiro Tabata, Kittiya Intaruck, Kentaro Uemura, et al. (+6)
39 [GO] 2021―Aug―23 Strong alkaline electrolyzed water efficiently inactivates SARS-CoV-2, other viruses, and Gram-negative bacteria Youichi Suzuki, Takayuki Hishiki, Akino Emi, Shoichi Sakaguchi, Ronko Itamura, Rain Yamamoto, et al. (+5)
40 [GO] 2021―Aug―15 A model for COVID-19-induced dysregulation of ACE2 shedding by ADAM17 Eamonn F. Healy, Marko Lilic
41 [GO] 2021―Aug―15 Mutation-induced changes in the receptor-binding interface of the SARS-CoV-2 Delta variant B.1.617.2 and implications for immune evasion Prabin Baral, Nisha Bhattarai, Md Lokman Hossen, Vitalii Stebliankin, Bernard S. Gerstman, Giri Narasimhan, Prem P. Chapagain
42 [GO] 2021―Jul―20 A non-RBM targeted RBD specific antibody neutralizes SARS-CoV-2 inducing S1 shedding Yingyi Long, Shuyi Song, Feiyang Luo, Xiaojian Han, Chao Hu, Yingming Wang, et al. (+6)
43 [GO] 2021―Jul―16 Repurposing nonnucleoside antivirals against SARS-CoV2 NSP12 (RNA dependent RNA polymerase): In silico-molecular insight Feroza Begum, Amit Kumar Srivastava, Upasana Ray
44 [GO] 2021―Jul―13 Natto extract, a Japanese fermented soybean food, directly inhibits viral infections including SARS-CoV-2 in vitro Mami Oba, Wen Rongduo, Akatsuki Saito, Tamaki Okabayashi, Tomoko Yokota, Junko Yasuoka, et al. (+5)
45 [GO] 2021―Jul―02 Analysis of SARS-CoV-2 nucleocapsid phosphoprotein N variations in the binding site to human 14-3-3 proteins Samanta Del Veliz, Lautaro Rivera, Diego M. Bustos, Marina Uhart
46 [GO] 2021―Jun―10 Optimization of reaction condition of recombinase polymerase amplification to detect SARS-CoV-2 DNA and RNA using a statistical method Kevin Maafu Juma, Teisuke Takita, Kenji Ito, Masaya Yamagata, Shihomi Akagi, Emi Arikawa, et al. (+6)
47 [GO] 2021―Jun―07 Therapeutic effect of CT-P59 against SARS-CoV-2 South African variant Dong-Kyun Ryu, Rina Song, Minsoo Kim, Young-Il Kim, Cheolmin Kim, Jong-In Kim, et al. (+10)
48 [GO] 2021―Jun―05 Analysis of the molecular mechanism of SARS-CoV-2 antibodies Dongfu Jin, Jing Wei, Jian Sun
49 [GO] 2021―May―29 Quantitative circular flow immunoassays with trained object recognition to detect antibodies to SARS-CoV-2 membrane glycoprotein Ryan Yuki Huang, Deron Raymond Herr
50 [GO] 2021―May―26 Similarities and differences in the conformational stability and reversibility of ORF8, an accessory protein of SARS-CoV-2, and its L84S variant Shinya Ohki, Tomohiro Imamura, Yasuki Higashimura, Kenji Matsumoto, Masashi Mori
51 [GO] 2021―May―21 Recognition through GRP78 is enhanced in the UK, South African, and Brazilian variants of SARS-CoV-2; An in silico perspective Ibrahim M. Ibrahim, Abdo A. Elfiky, Alaa M. Elgohary
52 [GO] 2021―May―11 SARS-Cov-2 spike protein fragment 674-685 protects mitochondria from releasing cytochrome c in response to apoptogenic influence Olena Kalashnyk, Olena Lykhmus, Mykhailo Izmailov, Lyudmyla Koval, Serhiy Komisarenko, Maryna Skok
53 [GO] 2021―Apr―21 Production in Escherichia coli of recombinant COVID-19 spike protein fragments fused to CRM197 Bellone Maria Laura, Puglisi Andrea, Dal Piaz Fabrizio, Hochkoeppler Alejandro
54 [GO] 2021―Apr―08 In-vitro acetylation of SARS-CoV and SARS-CoV-2 nucleocapsid proteins by human PCAF and GCN5 Dai Hatakeyama, Takeshi Masuda, Ryosuke Miki, Sumio Ohtsuki, Takashi Kuzuhara
55 [GO] 2021―Mar―26 ALG-097111, a potent and selective SARS-CoV-2 3-chymotrypsin-like cysteine protease inhibitor exhibits in vivo efficacy in a Syrian Hamster model Koen Vandyck, Rana Abdelnabi, Kusum Gupta, Dirk Jochmans, Andreas Jekle, Jerome Deval, et al. (+18)
56 [GO] 2021―Mar―26 Targeted design of drug binding sites in the main protease of SARS-CoV-2 reveals potential signatures of adaptation Aditya K. Padhi, Timir Tripathi
57 [GO] 2021―Mar―24 SARS-CoV-2 spike protein interactions with amyloidogenic proteins: Potential clues to neurodegeneration Danish Idress, Vijay Kumar
58 [GO] 2021―Mar―19 A tissue- and gender-specific regulation of the SARS-CoV-2 receptor ACE2 by p53 in pigs Yue Zhang, Guanglin Niu, Tatiana Flisikowska, Angelika Schnieke, Krzysztof Flisikowski
59 [GO] 2021―Mar―15 A rapid, point-of-care red blood cell agglutination assay detecting antibodies against SARS-CoV-2 Robert L. Kruse, Yuting Huang, Heather Smetana, Eric A. Gehrie, Tim K. Amukele, Aaron A.R. Tobian, et al. (+2)
60 [GO] 2021―Feb―26 SARS-CoV-2 variants combining spike mutations and the absence of ORF8 may be more transmissible and require close monitoring Filipe Pereira
61 [GO] 2021―Feb―15 Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity Sandipan Chakraborty
62 [GO] 2021―Feb―13 Application technology to fight the COVID-19 pandemic: Lessons learned in Thailand Kannikar Intawong, Debra Olson, Suwat Chariyalertsak
63 [GO] 2021―Feb―10 EGCG, a green tea polyphenol, inhibits human coronavirus replication in vitro Minsu Jang, Rackhyun Park, Yea-In Park, Yeo-Eun Cha, Ayane Yamamoto, Jin I. Lee, Junsoo Park
64 [GO] 2021―Feb―04 H7N9 pandemic preparedness: A large-scale production of a split inactivated vaccine Eduardo Alfredo Adami, Stefanni Liliane Chavez Rico, Milena Apetito Akamatsu, Cosue Miyaki, Isaías Raw, Dourival de Oliveira, et al. (+8)
65 [GO] 2021―Jan―29 5-amino levulinic acid inhibits SARS-CoV-2 infection Yasuteru Sakurai, Mya Myat Ngwe Tun, Yohei Kurosaki, Takaya Sakura, Daniel Ken Inaoka, Kiyotaka Fujine, et al. (+3)
66 [GO] 2021―Jan―22 The Nucleocapsid protein triggers the main humoral immune response in COVID-19 patients Veronique A.J. Smits, Esperanza Hernández-Carralero, María Cristina Paz-Cabrera, Elisa Cabrera, Yeray Hernández-Reyes, Juan Ramón Hernández-Fernaud, et al. (+4)
67 [GO] 2021―Jan―15 ATP biphasically modulates LLPS of SARS-CoV-2 nucleocapsid protein and specifically binds its RNA-binding domain Mei Dang, Yifan Li, Jianxing Song
68 [GO] 2021―Jan―15 RNA sequence and ligand binding alter conformational profile of SARS-CoV-2 stem loop II motif Ali H. Aldhumani, Md Ismail Hossain, Emily A. Fairchild, Hannah Boesger, Emily C. Marino, Mason Myers, Jennifer V. Hines
69 [GO] 2021―Jan―10 Nonlinear adaptive control of COVID-19 with media campaigns and treatment Boqiang Cao, Ting Kang
70 [GO] 2021―Jan―08 The papain-like protease of coronaviruses cleaves ULK1 to disrupt host autophagy Yasir Mohamud, Yuan Chao Xue, Huitao Liu, Chen Seng Ng, Amirhossein Bahreyni, Eric Jan, Honglin Luo
71 [GO] 2021―Jan―06 The inhibitory effects of PGG and EGCG against the SARS-CoV-2 3C-like protease Wei-Chung Chiou, Jui-Chieh Chen, Jinn-Moon Yang, Lih-Hwa Hwang, Yi-Shuan Lyu, Hsin-Yi Yang, Cheng Huang
72 [GO] 2021―Jan―01 Pathogenesis of COVID-19 and the quality control of nucleic acid detection Xiao-Dong Mao, Taiping Li, Zhirong Xu, Kangsheng Liu
73 [GO] 2020―Dec―26 In silico study of the potential interactions of 4′-acetamidechalcones with protein targets in SARS-CoV-2 Francisco Wagner Q. Almeida-Neto, Maria Geysillene Castro Matos, Emanuelle M. Marinho, Márcia M. Marinho, Ramon R.P.P.B. de Menezes, Tiago L. Sampaio, et al. (+6)
74 [GO] 2020―Dec―24 Comprehensive analysis of COVID-19 during pregnancy Kathryn M. Moore, Mehul S. Suthar
75 [GO] 2020―Dec―13 Overexpression of SARS-CoV-2 protein ORF6 dislocates RAE1 and NUP98 from the nuclear pore complex Koki Kato, Dini Kurnia Ikliptikawati, Akiko Kobayashi, Hiroya Kondo, Keesiang Lim, Masaharu Hazawa, Richard W. Wong
76 [GO] 2020―Dec―09 Range of reproduction number estimates for COVID-19 spread Damiano Pasetto, Joseph C. Lemaitre, Enrico Bertuzzo, Marino Gatto, Andrea Rinaldo
77 [GO] 2020―Dec―05 A perspective on early detection systems models for COVID-19 spreading Chiara Vianello, Fernanda Strozzi, Paolo Mocellin, Elisa Cimetta, Bruno Fabiano, Flavio Manenti, et al. (+2)
78 [GO] 2020―Dec―03 Identification of antiviral antihistamines for COVID-19 repurposing Leah R. Reznikov, Michael H. Norris, Rohit Vashisht, Andrew P. Bluhm, Danmeng Li, Yan-Shin J. Liao, et al. (+3)
79 [GO] 2020―Nov―28 Molecular docking of potential SARS-CoV-2 papain-like protease inhibitors Daoqun Li, Junwen Luan, Leiliang Zhang
80 [GO] 2020―Nov―28 The biogenesis of SARS-CoV-2 spike glycoprotein: Multiple targets for host-directed antiviral therapy Silvia Santopolo, Anna Riccio, M. Gabriella Santoro
81 [GO] 2020―Nov―28 Structural stability of SARS-CoV-2 virus like particles degrades with temperature A. Sharma, B. Preece, H. Swann, X. Fan, R.J. McKenney, K.M. Ori-McKenney, et al. (+2)
82 [GO] 2020―Nov―28 Immunomodulation for the management of severe SARS-CoV2 infections. State of the art and review of the literature Erica Bacca, Margherita Digaetano, Marianna Meschiari, Erica Franceschini, Marianna Menozzi, Gianluca Cuomo, Cristina Mussini
83 [GO] 2020―Nov―28 Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity Sandipan Chakraborty
84 [GO] 2020―Nov―21 The main protease and RNA-dependent RNA polymerase are two prime targets for SARS-CoV-2 Zhenming Jin, Haofeng Wang, Yinkai Duan, Haitao Yang
85 [GO] 2020―Nov―20 Remdesivir: From Ebola to COVID-19 M. Gabriella Santoro, Ernesto Carafoli
86 [GO] 2020―Nov―20 Identifying and repurposing antiviral drugs against severe acute respiratory syndrome coronavirus 2 with in silico and in vitro approaches Koichi Watashi
87 [GO] 2020―Nov―20 Diamond Light Source: contributions to SARS-CoV-2 biology and therapeutics Martin A. Walsh, Jonathan M. Grimes, David I. Stuart
88 [GO] 2020―Nov―20 Dual ELISA using SARS-CoV-2 nucleocapsid protein produced in E. coli and CHO cells reveals epitope masking by N-glycosylation Airi Rump, Robert Risti, Mai-Ly Kristal, Jekaterina Reut, Vitali Syritski, Aivar Lookene, Sirje Ruutel Boudinot
89 [GO] 2020―Nov―17 Development of a nano-luciferase based assay to measure the binding of SARS-CoV-2 spike receptor binding domain to ACE-2 Marcelo A. Lima, Mark Skidmore, Farhat Khanim, Alan Richardson
90 [GO] 2020―Nov―17 Vaccine-induced protection in aging adults and pandemic response Theodore Schenkelberg
91 [GO] 2020―Nov―13 A nidovirus perspective on SARS-CoV-2 Anastasia A. Gulyaeva, Alexander E. Gorbalenya
92 [GO] 2020―Nov―13 Functional importance of the D614G mutation in the SARS-CoV-2 spike protein Cody B. Jackson, Lizhou Zhang, Michael Farzan, Hyeryun Choe
93 [GO] 2020―Nov―11 Application technology to fight the COVID-19 pandemic: Lessons learned in Thailand Kannikar Intawong, Debra Olson, Suwat Chariyalertsak
94 [GO] 2020―Nov―07 T-cell dysregulation in COVID-19 Bahire Kalfaoglu, José Almeida-Santos, Chanidapa Adele Tye, Yorifumi Satou, Masahiro Ono
95 [GO] 2020―Nov―07 Proactive and blended approach for COVID-19 control in Taiwan Hao-Yuan Cheng, Angela Song-En Huang
96 [GO] 2020―Nov―07 Biochemical and Biophysical Research Communications History of the COVID-19 pandemic: Origin, explosion, worldwide spreading Sara Platto, Yanqing Wang, Jinfeng Zhou, Ernesto Carafoli
97 [GO] 2020―Nov―07 Evolution patterns of SARS-CoV-2: Snapshot on its genome variants Marta Giovanetti, Francesca Benedetti, Giovanni Campisi, Alessandra Ciccozzi, Silvia Fabris, Giancarlo Ceccarelli, et al. (+5)
98 [GO] 2020―Nov―07 Humoral immune responses and neutralizing antibodies against SARS-CoV-2; implications in pathogenesis and protective immunity Jorge Carrillo, Nuria Izquierdo-Useros, Carlos Ávila-Nieto, Edwards Pradenas, Bonaventura Clotet, Julià Blanco
99 [GO] 2020―Nov―05 Host-directed editing of the SARS-CoV-2 genome Tobias Mourier, Mukhtar Sadykov, Michael J. Carr, Gabriel Gonzalez, William W. Hall, Arnab Pain
100 [GO] 2020―Nov―05 The D614G mutations in the SARS-CoV-2 spike protein: Implications for viral infectivity, disease severity and vaccine design Danielle C. Groves, Sarah L. Rowland-Jones, Adrienn Angyal
101 [GO] 2020―Nov―02 Obesity alters Ace2 and Tmprss2 expression in lung, trachea, and esophagus in a sex-dependent manner: Implications for COVID-19 Dylan C. Sarver, G. William Wong
102 [GO] 2020―Oct―28 Laboratory testing for the diagnosis of COVID-19 Christopher Koon Chi Lai, Wilson Lam
103 [GO] 2020―Oct―26 Identifying SARS-CoV-2 infections in South Africa: Balancing public health imperatives with saving lives Cheryl Baxter, Quarraisha Abdool Karim, Salim S. Abdool Karim
104 [GO] 2020―Oct―23 T cell immunity to SARS-CoV-2 following natural infection and vaccination Anthony T. DiPiazza, Barney S. Graham, Tracy J. Ruckwardt
105 [GO] 2020―Oct―21 Lost in deletion: The enigmatic ORF8 protein of SARS-CoV-2 Luca Zinzula
106 [GO] 2020―Oct―21 The broad spectrum host-directed agent ivermectin as an antiviral for SARS-CoV-2? David A. Jans, Kylie M. Wagstaff
107 [GO] 2020―Oct―16 Biodiversity loss and COVID-19 pandemic: The role of bats in the origin and the spreading of the disease Sara Platto, Jinfeng Zhou, Yanqing Wang, Huo Wang, Ernesto Carafoli
108 [GO] 2020―Oct―10 Leveraging coronavirus binding to gangliosides for innovative vaccine and therapeutic strategies against COVID-19 Jacques Fantini, Henri Chahinian, Nouara Yahi
109 [GO] 2020―Oct―10 Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies Meng Yuan, Hejun Liu, Nicholas C. Wu, Ian A. Wilson
110 [GO] 2020―Oct―03 High-resolution structure and biophysical characterization of the nucleocapsid phosphoprotein dimerization domain from the Covid-19 severe acute respiratory syndrome coronavirus 2 Luca Zinzula, Jerome Basquin, Stefan Bohn, Florian Beck, Sven Klumpe, Günter Pfeifer, et al. (+4)
111 [GO] 2020―Sep―30 Chloroquine and hydroxychloroquine in the prophylaxis and therapy of COVID-19 infection Ernesto Carafoli
112 [GO] 2020―Sep―18 Machine learning methods accurately predict host specificity of coronaviruses based on spike sequences alone Kiril Kuzmin, Ayotomiwa Ezekiel Adeniyi, Arthur Kevin DaSouza, Deuk Lim, Huyen Nguyen, Nuria Ramirez Molina, et al. (+3)
113 [GO] 2020―Sep―14 The expression of SARS-CoV-2 receptor ACE2 and CD147, and protease TMPRSS2 in human and mouse brain cells and mouse brain tissues Jialu Qiao, Weiling Li, Jian Bao, Qian Peng, Dongmei Wen, Jianing Wang, Binlian Sun
114 [GO] 2020―Sep―11 Potent antiviral effect of silver nanoparticles on SARS-CoV-2 Sundararaj S. Jeremiah, Kei Miyakawa, Takeshi Morita, Yutaro Yamaoka, Akihide Ryo
115 [GO] 2020―Sep―04 RNA-dependent RNA polymerase: Structure, mechanism, and drug discovery for COVID-19 Yi Jiang, Wanchao Yin, H. Eric Xu
116 [GO] 2020―Aug―25 Andrographolide and its fluorescent derivative inhibit the main proteases of 2019-nCoV and SARS-CoV through covalent linkage Tzu-Hau Shi, Yi-Long Huang, Chiao-Che Chen, Wen-Chieh Pi, Yu-Ling Hsu, Lee-Chiang Lo, et al. (+3)
117 [GO] 2020―Aug―15 Mutations in the phosphorylation sites of SARS-CoV-2 encoded nucleocapsid protein and structure model of sequestration by protein 14-3-3 H.Y. Lim Tung, Pierre Limtung
118 [GO] 2020―Jul―21 Establishment and validation of a drug-target microarray for SARS-CoV-2 Peng Chen, Zehua Zeng, Hongwu Du
119 [GO] 2020―Jul―14 Acidic electrolyzed water potently inactivates SARS-CoV-2 depending on the amount of free available chlorine contacting with the virus Yohei Takeda, Hiroshi Uchiumi, Sachiko Matsuda, Haruko Ogawa
120 [GO] 2020―Jun―20 SARS-CoV-2 E protein is a potential ion channel that can Be inhibited by Gliclazide and Memantine Prabhat Pratap Singh Tomar, Isaiah T. Arkin
121 [GO] 2020―Jun―16 Proteasome activator PA28γ-dependent degradation of coronavirus disease (COVID-19) nucleocapsid protein Haiyang Zhang, Jialu Tu, Chulei Cao, Ting Yang, Liangcai Gao
122 [GO] 2020―Jun―09 Efficient production of recombinant SARS-CoV-2 spike protein using the baculovirus-silkworm system Ryosuke Fujita, Masato Hino, Takeru Ebihara, Takumi Nagasato, Akitsu Masuda, Jae Man Lee, et al. (+8)
123 [GO] 2020―Jun―08 Genetic variants that influence SARS-CoV-2 receptor TMPRSS2 expression among population cohorts from multiple continents Lalu Muhammad Irham, Wan-Hsuan Chou, Marcus J. Calkins, Wirawan Adikusuma, Shie-Liang Hsieh, Wei-Chiao Chang
124 [GO] 2020―May―29 Altered COVID-19 receptor ACE2 expression in a higher risk group for cerebrovascular disease and ischemic stroke Choi Ji-Young, Lee Hye-Kyung, Park Jung Hyun, Cho Sun-Jung, Kwon Munjin, Jo Chulman, Koh Young Ho
125 [GO] 2020―May―14 Interaction of the spike protein RBD from SARS-CoV-2 with ACE2: Similarity with SARS-CoV, hot-spot analysis and effect of the receptor polymorphism Houcemeddine Othman, Zied Bouslama, Jean-Tristan Brandenburg, Jorge da Rocha, Yosr Hamdi, Kais Ghedira, et al. (+2)
126 [GO] 2020―May―06 Stability of RNA sequences derived from the coronavirus genome in human cells Hiroyasu Wakida, Kentaro Kawata, Yuta Yamaji, Emi Hattori, Takaho Tsuchiya, Youichiro Wada, et al. (+2)
127 [GO] 2020―Apr―30 Biochemical characterization of SARS-CoV-2 nucleocapsid protein Weihong Zeng, Guangfeng Liu, Huan Ma, Dan Zhao, Yunru Yang, Muziying Liu, et al. (+10)
128 [GO] 2020―Apr―09 A possible strategy to fight COVID-19: Interfering with spike glycoprotein trimerization Pietro Bongini, Alfonso Trezza, Monica Bianchini, Ottavia Spiga, Neri Niccolai
129 [GO] 2020―Mar―19 Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses Furong Qi, Shen Qian, Shuye Zhang, Zheng Zhang
130 [GO] 2020―Mar―19 Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection Junwen Luan, Yue Lu, Xiaolu Jin, Leiliang Zhang
131 [GO] 2020―Feb―17 Structure analysis of the receptor binding of 2019-nCoV Yun Chen, Yao Guo, Yihang Pan, Zhizhuang Joe Zhao
 [1] 

131 Results       Page 1


[de][en]

Last change 2023―Apr―13 19:50:14 UTC

© Daten-Quadrat 2022       Done in 0.018 sec